FDA 483 - Formulation Technology, Inc. - November 09, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Formulation Technology, Inc. in Oakdale, CA, a dietary supplement manufacturer, received a Form 483 for significant deficiencies in their quality control and specification establishment. The inspection revealed failures to establish adequate identity, purity, strength, and composition specifications for both components and finished products, along with a lack of contamination limits. Additionally, quality control personnel failed to properly approve or reject specifications, indicating systemic issues in their quality system.
ID · 14adb049-a8aa-4515-be12-252940d2fabb